跳转至内容
Merck
CN

30906

蓖麻油,乙氧基化

别名:

PEG-35 蓖麻油, 聚氧乙烯蓖麻油

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

化学文摘社编号:
UNSPSC Code:
12161900
NACRES:
NA.25
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


description

non-ionic

Quality Level

form

paste

impurities

alkalinity, complies, ≤ acetic acid (≤0.5 g/100g (%) verfied on random samples only), ≤0.1% oleic acid, ≤0.1% palmitic acid, ≤0.2% sulfated ash (verfied on random samples only), ≤0.20% ricinoleic acid, ≤0.5% water, ≤1 ppm ethylene oxide (verfied on random samples only), ≤1.0% free fatty acids, ≤10 ppm dioxan (verfied on random samples only), ≤10 ppm heavy metals (verfied on random samples only), ≤620 ppm diethylene glycol (verfied on random samples only), ≤620 ppm ethylene glycol (verfied on random samples only)

ign. residue

≤0.2%

pH

5.0-7.0 (1 g/10 mL in H2O)

viscosity

600-750 mPa.s(25 °C)

acid value

≤2.0 mg KOH/g

hydroxyl value

65‑78 mg KOH/g

iodine value

25‑35 g/100g

saponification value

65‑70 mg KOH/g

cation traces

K: ≤15 ppm

SMILES string

ClCC(OC(=O)N)CCl

InChI

1S/C4H7Cl2NO2/c5-1-3(2-6)9-4(7)8/h3H,1-2H2,(H2,7,8)

InChI key

JMNCUXPHXKHBPY-UHFFFAOYSA-N

Application

乙氧基化蓖麻油可用于乳化和溶解油类和其它不溶于水的物质。 与乙氧基化蓖麻油相似,但含水量较低,且粘度不同。

Analysis Note

相对密度 D (25/25) 1.05-1.06

Legal Information

Cremophor is a registered trademark of BASF SE


Still not finding the right product?

Explore all of our products under 蓖麻油,乙氧基化


存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

494.6 °F - Not applicable

flash_point_c

257 °C - Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Ming-Kung Yeh et al.
AAPS PharmSciTech, 10(1), 166-171 (2009-02-19)
The formulation study of tenoxicam, a poorly water-soluble drug, was developed by use of a ternary cosolvent system and has significantly enhanced the solubility. Additionally, the relative bioavailability of testing formulation was also evaluated by New Zealand rabbit with a
Hong-Tao Song et al.
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 31(17), 1413-1417 (2006-11-08)
To prepare a sustained-release formulation of traditional Chinese medicine compound recipe by adopting time-controlled release techniques. Shuxiong tablets were chosen as model drug. The prescription and technique of core tablets were formulated with selecting disintegrating time and swelling volume of
Jing Yao et al.
International journal of pharmaceutics, 352(1-2), 256-262 (2007-12-07)
The purpose of this study was to characterize the in vitro properties of a number of chitosan-based microemulsions containing nobiletin and determine its distribution in mice brain following i.v. administration. The phase behavior and properties of chitosan-based microemulsions were investigated



全球贸易项目编号

货号GTIN
30906-1KG04061826675250